Skip to main content
Livermore
Livermore
ZHEN

RFG Advisory, LLC

SEC CIK
0001633387
Latest filing
Jul 15, 2026

WST holding history

West Pharmaceutical Services Inc in every 13F filed by RFG Advisory, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

WST overviewAll 13F holders of WSTFull Q2 2026 holdings

Shares (Q1 2026)
0
Sold out in Q1 2026
Value
$0
% of portfolio
0.0%
Quarters held
20
Since Q1 2021
Holdings of WST by RFG Advisory, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20260$00.0%−1,587−100.0%Sold outHolders
Q4 20251,587$436.7K<0.1%−646−28.9%ReducedHolders
Q3 20252,233$585.8K<0.1%+47+2.2%AddedHolders
Q2 20252,186$478.4K<0.1%+288+15.2%AddedHolders
Q1 20251,898$425.0K<0.1%+219+13.0%AddedHolders
Q4 20241,679$550.1K<0.1%+15+0.9%AddedHolders
Q3 20241,664$499.6K<0.1%+165+11.0%AddedHolders
Q2 20241,499$493.9K<0.1%+34+2.3%AddedHolders
Q1 20241,465$579.9K<0.1%+33+2.3%AddedHolders
Q4 20231,432$504.4K<0.1%−29−2.0%ReducedHolders
Q3 20231,461$548.2K<0.1%+20+1.4%AddedHolders
Q2 20231,441$551.2K<0.1%+259+21.9%AddedHolders
Q1 20231,182$409.7K<0.1%+26+2.2%AddedHolders
Q4 20221,156$315.5K<0.1%+86+8.0%AddedHolders
Q3 20221,070$240.0K<0.1%+64+6.4%AddedHolders
Q2 20221,006$344.0K<0.1%−122−10.8%ReducedHolders
Q1 20221,128$463.0K<0.1%−217−16.1%ReducedHolders
Q4 20211,345$631.0K<0.1%−27−2.0%ReducedHolders
Q3 20211,372$583.0K<0.1%−69−4.8%ReducedHolders
Q2 20211,441$518.0K<0.1%−294−16.9%ReducedHolders
Q1 20211,735$489.0K0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.